Global Ganja Report

The Colorado Independent reported Dec. 8 that Colorado is joining Rhode Island and Washington state in petitioning the federal government to "change the schedule of marijuana under the Controlled Substances Act." Colorado is required by state law to file its own such request before the end of the year. The Centennial State legalized medical marijuana in 2000 through voter approval of Amendment 20, which was itself later amended by three enabling laws. One such law passed last year, HB 10-1284, requires:

Governors Christine Gregoire (D-WA) and Lincoln Chafee (I-RI) announced at a press conference in Olympia Nov. 30 that they are jointly filing a federal petition to reclassify cannabis for medical use. Under the Controlled Substances Act, the federal government considers cannabis a Schedule I substance, a dangerous drug with no medical value. The rescheduling petition filed by governors Gregoire and Chafee comes after their administrations were sent letters threatening medical marijuana producers and distributors and the implementation of state laws.

Advocacy group Americans for Safe Access (ASA) issued a letter Nov. 17 urging that Los Angeles' prestigious Cedars-Sinai Medical Center promptly re-list 63-year-old patient Norman B. Smith for a liver transplant. Smith was diagnosed with inoperable liver cancer in 2009 and became eligible for a transplant at Cedars-Sinai the following year. Smith's oncologist at Cedars-Sinai, Dr. Steven Miles, approved of his cannabis use to deal with the effects of chemotherapy and pain from an unrelated back surgery. But in February he was removed from the transplant list after testing positive for cannabis use.

Survey data collected from members of the Berkeley Patients Group, one of California's most prominent medical marijuana collectives, indicates that most patients reduce their use of prescription medications following their initiation of cannabis therapy. The anonymous survey found that 66% of respondents said that they consumed cannabis as a prescription drug substitute. Many said they preferred cannabis because it caused fewer side effects than conventional medications.

Nine Congress members on Oct. 31 issued an open letter to President Obama urging him to put a halt to new aggressive Justice Department tactics aimed at dismantling California's medical marijuana industry. "It's unconscionable...to endanger the lives of patients," the reps state in the strongly worded letter, which calls for rescheduling cannabis. It especially urges support for HR 1983, the States' Medical Marijuana Patient Protection Act, which was introduced by Rep. Barney Frank (D-MA) earlier this year.

Trustees of the California Medical Association, representing more than 35,000 physicians statewide, on Oct. 14 adopted a position calling for legalization of cannabis at their annual meeting in Anaheim—becoming the first major medical association in the nation to do so. Dr. Donald Lyman, the Sacramento physician who wrote the group's new policy, attributed the move to growing frustration over California's medical marijuana law, which puts practitioners in the situation of having to decide whether to recommend a substance that is illegal under federal law.

Northern California's Humboldt Plant Fertilizers (HPF) announced Sept. 22 that it will become "the only natural liquid plant nutrient company banning any use of slaughterhouse by-products such as the bone meal, blood meal, and feather meal almost universally found in all other natural fertilizer products." Every product manufactured by HPF will now bear the "Holy Cow" symbol—a smiling bovine head with a halo and the words "We never use slaughterhouse by-products."

Cannabis administered in a timely manner may block the development of post-traumatic stress disorder symptoms in rats, a new study conducted at Israel's Haifa University finds. The study, published in Neuropsychopharmacology journal, found that rats given cannabis within 24 hours of a traumatic experience successfully avoided PTSD symptoms. "There is a critical 'window of time' after trauma, during which synthetic marijuana can help prevent symptoms similar to PTSD in rats," said study leader Dr. Irit Akirav.